Venture&Growth
![](https://gildehealthcare.com/wp-content/uploads/2021/05/Vesper-medical.png)
Location
Wayne (PA), USA
Venture&Growth
All Portfolio items
See full Venture&Growth portfolio
US-based MedTech company developing a novel venous stent.
Vesper Medical is a medical device company dedicated to the development of a novel venous stent for the treatment of a variety of venous diseases. The company had achieved CE Mark and has initiated the VIVID trial in the US for FDA approval. Vesper was founded in 2016 as a spin-out of Intact Vascular.
In 2022, Royal Philips acquired 100% of the Vesper shares, providing Gilde with an attractive return within a three-year holding period.
More Vesper Medical news
Vesper Medical Announces First Enrollment in the VIVID Trial
Gilde Healthcare co-leads $37M financing of Vesper Medical to complete development of its Duo Venous Stent System
Fire1
Irish MedTech company focused on remote monitoring of heart failure patients.
![](https://gildehealthcare.com/wp-content/uploads/2021/07/Fire-1-final-1.png)
Volta Medical
French Healthtech company developing AI software solutions to assist in cardiac operations.
![](https://gildehealthcare.com/wp-content/uploads/2021/05/Volta.png)
Amphista Therapeutics
Amphista Therapeutics is a UK-based biopharmaceutical company creating first-in-class therapeutics that harness the body’s natural...
![](https://gildehealthcare.com/wp-content/uploads/2021/06/Amphista.png)